December 17, 2020 Brandon Suffel
It’s about time SuffelStocks makes its notorious return. There is nothing better than a hapless college student analyzing the stock market with a passion for Political Science. So what’s changed? Without a doubt, the market has taken off since the summer. The DOW Jones Industrial Average reached 30,000 & the EV sector is doing well. I was apart of it all. Although I didn’t post any articles relating to these victories, I was a strong advocate on Stocktwits and Twitter. This time around, I’ll be here for good, and I’m holding myself accountable to this pledge. So let’s take the ride.
The vaccine is here finally, and it’s time we let the coronavirus pack its bags and take the first flight out of the United States. That’s not possible. It will stay here forever, for good, but this time around, we have a weapon to fight against it. The Pfizer vaccine was FDA emergency approved on the whims of desperate measures that were necessary. So why is the stock down right now? Is it because there isn’t enough of the vaccine to go around right now? Is it because New York Politicians are killing small businesses even though they’ve promised to be more lenient once the vaccine comes? These are just some of the many questions we deserve to hear answers to;
Since last Friday, when the news broke of FDA approval, and this past Monday, when the first subject received inoculation, Pfizer’s stock has been on a downward trend for bullish investors. How can it be? I’d assume fundamentals are key to optimistic investing, but the stock price won’t do its bloody deed. The bears are in the mix and eager to attack and viciously eat away at any poor news from Pfizer’s vaccine progress.
So far today, Pfizer’s stock has experienced substantial bullish resiliency. As we approached the closing bell, investors in $PFE were eager for more gains from today’s bull run in hopes the trend would fare into the after hours. Tomorrow could be a tough day for Pfizer bulls since the sentiment is down roughly one and a half points.
Although there is still hope for Pfizer investors, Biden plans to take the vaccine soon and in a public manner for the entire social media world to watch and admire in glory. I won’t be watching.
It’s Looking Great for Moderna though
Moderna, another vaccine/weapon to fight against COVID-19, is bound for approval by the FDA no later than tomorrow. You have my word. (It was just FDA approved as we speak) So what’s better than one vaccine? Two, you may assume. (I can’t lie, I’m a tad conflicted when it comes to a choice between the two). The Pfizer vaccine comes in what, two doses? And the Moderna vaccine alters your RNA so that your immune system can assertively assume the COVID-19 cells are nothing but a heap of fruit flies. There is hope.
Pfizer’s stock wasn’t the only one to fall; Moderna also fared the same bearish behavior this past week. The $MRNA share price dropped enough to scare investors into selling and day traders into shorting. Oh, what a ride for these two; it sure has been wicked. Since today’s optimism from imperative FDA approval, $MRNA share prices are up & they are up big until they fell in the after-hours…. what a bummer.
The EV Sector is the ‘New’
The EV sector is the new hip-style for relatively new investors and those trying to make a few extra bucks. Why not hop on the train? After all, the future is protecting our precious environment at all costs. And with the new Biden and Harris administration, there’s a pledge set in stone to protect the environment by eliminating gasoline-hungry vehicles and factories that emit harmful pollution into our atmosphere.
So which are the most popular? Well, I guess I’ll share my secret sauce: $PLUG, $BLNK, $SOLO, $AYRO, $FCEL, and $CLSK have worked very well for me so far.
Each stock is relatively diverse and offers more than just hydrogen-fuel powered forklifts or interchangeable batteries.
Since the summer, almost every one of those stocks above is up more than 50%. How about that.